Literature DB >> 19365408

Immunogenic and tolerogenic cell death.

Douglas R Green1, Thomas Ferguson, Laurence Zitvogel, Guido Kroemer.   

Abstract

The immune system is routinely exposed to dead cells during normal cell turnover, injury and infection. Mechanisms must exist to discriminate between different forms of cell death to correctly eliminate pathogens and promote healing while avoiding responses to self, which can result in autoimmunity. However, an effective immune response against host tissue is often needed to eliminate tumours following treatment with chemotherapeutic agents that trigger tumour cell death. Consequently, a central problem in immunology is to understand how the immune system determines whether cell death is immunogenic, tolerogenic or 'silent'.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19365408      PMCID: PMC2818721          DOI: 10.1038/nri2545

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  121 in total

Review 1.  Cross-presentation, dendritic cells, tolerance and immunity.

Authors:  W R Heath; F R Carbone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  Death through a tragedy: mitotic catastrophe.

Authors:  H Vakifahmetoglu; M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2008-04-11       Impact factor: 15.828

3.  Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome.

Authors:  L Q Le; J H Kabarowski; Z Weng; A B Satterthwaite; E T Harvill; E R Jensen; J F Miller; O N Witte
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

4.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.

Authors:  Hirotaka Kazama; Jean-Ehrland Ricci; John M Herndon; George Hoppe; Douglas R Green; Thomas A Ferguson
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

5.  The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.

Authors:  T Panaretakis; N Joza; N Modjtahedi; A Tesniere; I Vitale; M Durchschlag; G M Fimia; O Kepp; M Piacentini; K-U Froehlich; P van Endert; L Zitvogel; F Madeo; G Kroemer
Journal:  Cell Death Differ       Date:  2008-05-09       Impact factor: 15.828

6.  A critical role for the proapoptotic protein bid in ultraviolet-induced immune suppression and cutaneous apoptosis.

Authors:  Sanjay Pradhan; Hee Kyung Kim; Christopher J Thrash; Maureen A Cox; Sudheer K Mantena; Jian-He Wu; Mohammad Athar; Santosh K Katiyar; Craig A Elmets; Laura Timares
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 7.  The forward genetic dissection of afferent innate immunity.

Authors:  B Beutler; E M Y Moresco
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 8.  Pattern recognition receptors in the immune response against dying cells.

Authors:  Pascale Jeannin; Sébastien Jaillon; Yves Delneste
Journal:  Curr Opin Immunol       Date:  2008-06-12       Impact factor: 7.486

9.  CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

Authors:  J M den Haan; S M Lehar; M J Bevan
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

10.  Role of antigen-presenting cells in mediating tolerance and autoimmunity.

Authors:  K M Garza; S M Chan; R Suri; L T Nguyen; B Odermatt; S P Schoenberger; P S Ohashi
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  399 in total

Review 1.  DNA-Based Biomaterials for Immunoengineering.

Authors:  Midori Maeda; Taisuke Kojima; Yang Song; Shuichi Takayama
Journal:  Adv Healthc Mater       Date:  2018-12-05       Impact factor: 9.933

2.  Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design.

Authors:  Yohei Mineharu; Gwendalyn D King; A K M G Muhammad; Serguei Bannykh; Kurt M Kroeger; Chunyan Liu; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

3.  Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1α.

Authors:  Yaël Berda-Haddad; Stéphane Robert; Paul Salers; Leila Zekraoui; Catherine Farnarier; Charles A Dinarello; Françoise Dignat-George; Gilles Kaplanski
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

4.  A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome.

Authors:  Zhi Zeng; Marina Hincapie; Sharon J Pitteri; Samir Hanash; Joost Schalkwijk; Jason M Hogan; Hong Wang; William S Hancock
Journal:  Anal Chem       Date:  2011-05-23       Impact factor: 6.986

Review 5.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

Review 6.  Macrophages clean up: efferocytosis and microbial control.

Authors:  Constance J Martin; Kristen N Peters; Samuel M Behar
Journal:  Curr Opin Microbiol       Date:  2013-12-05       Impact factor: 7.934

7.  Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.

Authors:  Hing-Yuen Yeung; Pui-Chi Lo; Dennis K P Ng; Wing-Ping Fong
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

Review 8.  Chemoimmunotherapy: reengineering tumor immunity.

Authors:  Gang Chen; Leisha A Emens
Journal:  Cancer Immunol Immunother       Date:  2013-02-07       Impact factor: 6.968

9.  Low dose gemcitabine increases the cytotoxicity of human Vγ9Vδ2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model.

Authors:  Teruki Shimizu; Mako Tomogane; Masatsugu Miyashita; Osamu Ukimura; Eishi Ashihara
Journal:  Oncoimmunology       Date:  2018-02-08       Impact factor: 8.110

10.  Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?

Authors:  Guido Moll; Jessica J Alm; Lindsay C Davies; Lena von Bahr; Nina Heldring; Lillemor Stenbeck-Funke; Osama A Hamad; Robin Hinsch; Lech Ignatowicz; Matthew Locke; Helena Lönnies; John D Lambris; Yuji Teramura; Kristina Nilsson-Ekdahl; Bo Nilsson; Katarina Le Blanc
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.